Abstract

In All-Russian Scientific Research Institute for Fundamental and Applied Parasitology of Animals and Plant – a branch of the Federal State Budget Scientific Institution "Federal Scientific Centre VIEV" a prototype of a new drug form of Ivermectin was developed for cutaneous use against endo- and ectoparasites. The dosage form is a transparent solution for application to the skin with an Ivermectin content of 0.5%. For the experiment, 18 white male rats weighing 180-200 g were selected, which were divided into 2 experimental and one control group of 6 heads each. The coat of all animals was shaved on the back with an area of about 5x5 cm. The drug was applied at doses of 5 000 and 10 000 mg / kg, the control group did not receive the drug. The LD50 of the Ivermectin dosage form is more than 10 000 mg / kg, according to GOST 12.1.007-76 the drug belongs to the 4th class of danger when applied to the skin. The drug does not have an irritating effect when applied once to intact rat skin.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.